Catalysts for $COLL
120 tracked
Aug 6, 2026
earnings
COLLEGIUM PHARMACEUTICAL, INC earnings
COLLEGIUM PHARMACEUTICAL, INC
→
May 7, 2026
earnings
COLLEGIUM PHARMACEUTICAL, INC earnings
COLLEGIUM PHARMACEUTICAL, INC
→
Mar 10, 2026
approval
QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Mar 9, 2026
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 27, 2026
approval
TAPENTADOL HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Jan 15, 2026
approval
METHYLPHENIDATE HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Dec 22, 2025
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Dec 22, 2025
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Dec 22, 2025
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Dec 22, 2025
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Sep 23, 2025
approval
APTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Sep 23, 2025
approval
METHYLPHENIDATE HYDROCHLORIDE — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Sep 23, 2025
approval
RELEXXII (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Sep 23, 2025
approval
JORNAY PM (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Sep 23, 2025
approval
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Sep 23, 2025
approval
QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
COLLEGIUM PHARMACEUTICAL, INC
→
Oct 31, 2024
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Oct 31, 2024
approval
XTAMPZA ER (OXYCODONE) — FDA approval
oxycodone ER
→
Oct 31, 2024
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Oct 31, 2024
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jun 14, 2024
approval
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jun 14, 2024
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→
Jun 14, 2024
approval
NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approval
tapentadol hydrochloride ER
→